نتایج جستجو برای: fcγriiia

تعداد نتایج: 216  

2015
Masaki Kurogochi Masako Mori Kenji Osumi Mami Tojino Shu-ichi Sugawara Shou Takashima Yuriko Hirose Wataru Tsukimura Mamoru Mizuno Junko Amano Akio Matsuda Masahiro Tomita Atsushi Takayanagi Shin-Ichiro Shoda Takashi Shirai Mitchell Ho

Many therapeutic antibodies have been developed, and IgG antibodies have been extensively generated in various cell expression systems. IgG antibodies contain N-glycans at the constant region of the heavy chain (Fc domain), and their N-glycosylation patterns differ during various processes or among cell expression systems. The Fc N-glycan can modulate the effector functions of IgG antibodies, s...

Journal: :Journal of immunological methods 2015
Piotr Pierog Murli Krishna Aaron Yamniuk Anil Chauhan Binodh DeSilva

BACKGROUND Administration of a biotherapeutic can result in the formation of anti-drug antibodies (ADAs). The resulting ADA can potentially form immune complexes (ICs) with the drug leading to altered pharmacokinetic (PK) profiles and/or adverse events. Furthermore the presence of such complexes may interfere with accurate PK assessment, and/or detection of ADA in immunogenicity assays. Here, w...

Journal: :Circulation. Cardiovascular genetics 2012
Sadeep Shrestha Howard Wiener Aditi Shendre Richard A Kaslow Jianming Wu Aaron Olson Neil E Bowles Hitendra Patel Jeffrey C Edberg Michael A Portman

BACKGROUND A functional polymorphism in the inhibitory IgG-Fc receptor gene FcγRIIB influences intravenous immunoglobulin (IVIG) response in Kawasaki disease (KD), a vasculitis preferentially affecting the coronary arteries in children. We tested the hypothesis that the polymorphisms in the activating receptors (FcγRIIA, FcγRIIIA, and FcγRIIIB) also influence susceptibility, IVIG treatment resp...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Jan Pander Moniek Heusinkveld Tahar van der Straaten Ekaterina S Jordanova Renée Baak-Pablo Hans Gelderblom Hans Morreau Sjoerd H van der Burg Henk-Jan Guchelaar Thorbald van Hall

PURPOSE In a recent randomized phase III clinical trial in metastatic colorectal cancer patients, the addition of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) cetuximab to bevacizumab and chemotherapy resulted in decreased progression-free survival, in particular for patients with the high-affinity FcγRIIIA. EXPERIMENTAL DESIGN The presence of natural killer (NK)...

2017
Gillian Dekkers Louise Treffers Rosina Plomp Arthur E. H. Bentlage Marcella de Boer Carolien A. M. Koeleman Suzanne N. Lissenberg-Thunnissen Remco Visser Mieke Brouwer Juk Yee Mok Hanke Matlung Timo K. van den Berg Wim J. E. van Esch Taco W. Kuijpers Diana Wouters Theo Rispens Manfred Wuhrer Gestur Vidarsson

Glycosylation of the immunoglobulin G (IgG)-Fc tail is required for binding to Fc-gamma receptors (FcγRs) and complement-component C1q. A variety of IgG1-glycoforms is detected in human sera. Several groups have found global or antigen-specific skewing of IgG glycosylation, for example in autoimmune diseases, viral infections, and alloimmune reactions. The IgG glycoprofiles seem to correlate wi...

2013
Alessandro Poggi Silvia Boero Alessandra Musso Maria Raffaella Zocchi

We have analyzed the effects of fluvastatin, an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase involved in mevalonate synthesis, on human NK cell-mediated anti-tumor cytolysis. Fluvastatin inhibited the activation of the small guanosin triphosphate binding protein (GTP) RhoA and the consequent actin redistribution induced by ligation of LFA1 involved in NK-tum...

Journal: :Glycobiology 2009
Mami Shibata-Koyama Shigeru Iida Akira Okazaki Katsuhiro Mori Kazuko Kitajima-Miyama Seiji Saitou Shingo Kakita Yutaka Kanda Kenya Shitara Koichi Kato Mitsuo Satoh

Human leukocyte receptor IIIa (Fc gamma RIIIa) plays an important role in mediating therapeutic antibodies' antibody-dependent cellular cytotoxicity (ADCC), which is closely related to the clinical efficacy of anticancer processes in humans in vivo. The removal of the core fucose from oligosaccharides attached to the Fc region of antibodies improves Fc gamma RIIIa binding, allowing the antibodi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید